During the past decade, Da Vinci Maganklinika conducted 6 clinical trials. In the 10-year time frame, 6 clinical trials started and 3 clinical trials were completed, i.e. on average, 50% percent of trials that started reached the finish line to date. In the past 5 years, 3 clinical trials started and 3 clinical trials were completed. i.e. 100% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Da Vinci Maganklinika" #1 collaborator was "Eli Lilly and Company" with 2 trials as a collaborator and "Brigham and Women's Hospital" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 2 trials.

According to Clinical.Site data, the most researched conditions in "Da Vinci Maganklinika" are "Heart Failure" (3 trials), "Bronchiectasis" (1 trials), "Dyslipidemia" (1 trials), "Refractory and/or Unexplained Chronic Cough" (1 trials) and "Type2 Diabetes" (1 trials). Many other conditions were trialed in "Da Vinci Maganklinika" in a lesser frequency.

Most popular intervention types in "Da Vinci Maganklinika" are "Drug" (6 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (6 trials), "Empagliflozin" (2 trials), "BAY1817080" (1 trials), "BI 1291583" (1 trials) and "Finerenone (BAY94-8862)" (1 trials). Other intervention names were less common.

The vast majority of trials in "Da Vinci Maganklinika" are 6 trials for "All" genders.

Currently, there are NaN active trials in "Da Vinci Maganklinika". undefined are not yet recruiting, 1 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 3 completed trials in Da Vinci Maganklinika, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Da Vinci Maganklinika, 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 4 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".